City File: Fisons rumours
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.FISONS, the struggling drugs group, has remained tight- lipped about how its interim dividend will shape up this week. The share price has suffered recently from speculation that the payout might be cut. But given relatively sound finances, a maintained dividend of 3.3p looks more likely.
A dismal half-year result is expected to fuel rumours that Fisons will not remain independent for much longer. Profits will dive from pounds 95m last year to around pounds 35m this time - a result that should not surprise the market, as the company issued a profit warning in June.
The share price might be buoyed at last week's level of about 178p because of continuing speculation that predators are on the prowl. Top of an extensive list are ICI and Boots.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments